BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11786977)

  • 1. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T; Honda M; Kaneko S; Kobayashi K
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
    Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.
    Shirasaki T; Honda M; Mizuno H; Shimakami T; Okada H; Sakai Y; Murakami S; Wakita T; Kaneko S
    J Infect Dis; 2010 Jul; 202(1):75-85. PubMed ID: 20497049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
    FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
    Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
    Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.
    Honda M; Ping LH; Rijnbrand RC; Amphlett E; Clarke B; Rowlands D; Lemon SM
    Virology; 1996 Aug; 222(1):31-42. PubMed ID: 8806485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
    Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
    J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
    Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
    Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity.
    She Y; Liao Q; Chen X; Ye L; Wu Z
    Arch Virol; 2008; 153(11):1991-7. PubMed ID: 18853100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines.
    Koev G; Duncan RF; Lai MM
    Virology; 2002 Jun; 297(2):195-202. PubMed ID: 12083818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNP L is required for the translation mediated by HCV IRES.
    Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
    Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
    Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
    Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.